Showing results (151-160 of 293) with videos related to
Sort By:
Pageof 30
Gynecologic Oncology|February 24, 2009
Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?Nadeem R Abu-Rustum, Fady Khoury-Collado, Neeta Pandit-Taskar, et al.Journal of Pediatric Hematology/Oncology|June 1, 2017
Epigenetic Combination Therapy for Children With Secondary Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) and Concurrent Solid Tumor RelapseChana L Glasser, Alice Lee, Don Eslin, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 18, 2020
SNMMI Procedure Standard/EANM Practice Guideline on Pediatric <sup>18</sup>F-FDG PET/CT for Oncology 1.0Reza Vali, Adam Alessio, Rene Balza, et al.The Lancet. Oncology|March 31, 2007
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trialChaitanya R Divgi, Neeta Pandit-Taskar, Achim A Jungbluth, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2014
Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remissionBrian H Kushner, Irene Y Cheung, Shakeel Modak, et al.Pediatric Blood & Cancer|March 19, 2011
Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastomaShakeel Modak, Irene Y Cheung, Brian H Kushner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastomaBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2025
SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass CharacterizationSteven P Rowe, Brian M Shuch, Mark W Ball, et al.Investigational New Drugs|August 7, 2012
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanomaPatrick A Ott, Richard D Carvajal, Neeta Pandit-Taskar, et al.Oncoimmunology|June 27, 2013
Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-<i>D</i>-glucan: A Phase I study in patients with chemoresistant neuroblastomaShakeel Modak, Brian H Kushner, Kim Kramer, et al.Pageof 30